Concepedia

Doug J. Bartels

DJ

16

Publications

1.7K

Citations

14

H-Index

1999

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Janssen (Belgium)

Janssen (United States)

Cornell University

Goethe University Frankfurt

Doug J. Bartels is an author at Vertex Pharmaceuticals (United States) specializing in medicine, viral hepatitis, and virology.

Top concepts

Publications per year

1999–2014

16

Publications

16

Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir

Christoph Sarrazin, Tara L. Kieffer, Doug J. Bartels et al. · Gastroenterology · 2007 · 611 citations

, , +11

Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects

Doug J. Bartels, Yi Zhou, Eileen Z. Zhang et al. · The Journal of Infectious Diseases · 2008 · 206 citations

Erf2, a Novel Gene Product That Affects the Localization and Palmitoylation of Ras2 in <i>Saccharomyces cerevisiae</i>

Doug J. Bartels, David A. Mitchell, Xiangwen Dong et al. · Molecular and Cellular Biology · 1999 · 177 citations · Full text

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

James C. Sullivan, Sandra De Meyer, Doug J. Bartels et al. · Clinical Infectious Diseases · 2013 · 164 citations · Full text

Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment

Doug J. Bartels, James C. Sullivan, Eileen Z. Zhang et al. · Journal of Virology · 2012 · 144 citations · Full text

Rows per page

1–5 of 16